GL1X · GenesisL1 explorer

Research workbench

Crystal structure of inhibitor tmc-353121 in complex with prefusion rsv F glycoprotein

Analyse Crystal structure of inhibitor tmc-353121 in complex with prefusion rsv F… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5EA5
Type
protein
Length
426 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fusion glycoprotein F0
UniProt
P03420
Ligands
TM3, SO4
Pockets
2 · best druggability 0.29

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
FFusion glycoprotein F0protein42630% helix, 35% strandP03420

Ligands and binding sites

  • TM3 · 2-[[6-[[[2-(3-hydroxypropyl)-5-methylphenyl]amino]methyl]-2-[[3-(4-morpholinyl)propyl]amino]-1H-benzimidazol-1-yl]methyl]-6-methyl-3-pyridinol · ligand · chains F
  • SO4 · Sulfate ion · ion · chains F
  • NHE · 2-[N-cyclohexylamino]ethane sulfonic acid · additive · chains F
  • TAR · D(-)-tartaric acid · additive · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1580.290.7514empty
2500.270.7513empty

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 5EA5 · Crystal Structure of Inhibitor TMC-353121 in Complex with Prefusion RSV F Glycoprotein · the same entry in another collection · chain F against F, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.